This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 200302-165OCv1 170/9/1022    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hopkins, P. M. Articles by Glanville, A. R. Search for Related Content PubMed PubMed Citation Articles by Hopkins, P. M. Articles by Glanville, A. R.

Association of Minimal Rejection in Lung Transplant Recipients with Obliterative Bronchiolitis

The Lung Transplant Unit, St. Vincent's Hospital, Sydney, Australia

Correspondence and requests for reprints should be addressed to Peter M. Hopkins, M.B.B.S., F.R.A.C.P., Queensland Heart-Lung Transplant Unit, The Prince Charles Hospital, Department of Thoracic Medicine, Rode Road, Chermside, Brisbane, Queensland, Australia 4032. E-mail: peterwakatipu{at}hotmail.com

The clinical significance of minimal acute rejection (grade A₁) in lung transplant recipients is unknown. We prospectively analyzed 1,159 transbronchial lung biopsies in 184 patients. Two hundred seventy-nine biopsies in 128 participants confirmed A₁ histology at a mean postoperative day of 229 ± 340. Sixty four of 255 surveillance A₁ lesions progressed to high-grade acute rejection by 3 months of follow-up, whereas 40 developed new lymphocytic bronchiolitis. Twenty-four A₁ biopsies were symptomatic, with only two cases progressing to high-grade rejection after steroid therapy. Seventy-eight of 184 patients experienced multiple ( 2) A₁ biopsies in the first 12 months after transplant. Bronchiolitis obliterans syndrome developed in 68% of patients with multiple A₁ lesions at a mean of 599 ± 435 days, compared with 43% of patients with one or less A₁ lesions at a mean of 819 ± 526 (p = 0.022). Eighteen patients experienced multiple A₁ biopsies after transplant in the absence of high-grade rejection episodes yet also developed earlier obliterative bronchiolitis (456 ± 245 days, p = 0.020). We conclude that for A₁ transbronchial lung biopsies, the conventional treatment of observation only is now challenged even in patients who are asymptomatic. Patients who experience multiple A₁ lesions develop an earlier onset of obliterative bronchiolitis and may warrant alternative immunosuppressive strategies.

Key Words: lung transplant • minimal rejection • obliterative bronchiolitis

This article has been cited by other articles:

				J. Gottlieb Review: Update on lung transplantation Therapeutic Advances in Respiratory Disease, August 1, 2008; 2(4): 237 - 247. [Abstract] [PDF]

				A. R. Glanville, C. L. Aboyoun, A. Havryk, M. Plit, S. Rainer, and M. A. Malouf Severity of Lymphocytic Bronchiolitis Predicts Long-Term Outcome after Lung Transplantation Am. J. Respir. Crit. Care Med., May 1, 2008; 177(9): 1033 - 1040. [Abstract] [Full Text] [PDF]

				J.-F. Cordier Challenges in pulmonary fibrosis {middle dot} 2 : Bronchiolocentric fibrosis Thorax, July 1, 2007; 62(7): 638 - 649. [Abstract] [Full Text] [PDF]

				R. Stovold, I. A. Forrest, P. A. Corris, D. M. Murphy, J. A. Smith, S. Decalmer, G. E. Johnson, J. H. Dark, J. P. Pearson, and C. Ward Pepsin, a Biomarker of Gastric Aspiration in Lung Allografts: A Putative Association with Rejection Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1298 - 1303. [Abstract] [Full Text] [PDF]

				H. Liu, L. Liu, B. S. Fletcher, and G. A. Visner Sleeping Beauty-based gene therapy with indoleamine 2,3-dioxygenase inhibits lung allograft fibrosis FASEB J, November 1, 2006; 20(13): 2384 - 2386. [Abstract] [Full Text] [PDF]

				M. Estenne and R. M. Kotloff Update in transplantation 2005. Am. J. Respir. Crit. Care Med., March 15, 2006; 173(6): 593 - 598. [Full Text] [PDF]

				G. Tino Clinical Year in Review III: Sleep-disordered Breathing, Interstitial Lung Disease, Lung Transplantation, and Pediatric Pulmonary Disease Proceedings of the ATS, November 1, 2005; 2(4): 251 - 254. [Full Text] [PDF]

				T. D. Bradley, Y. E. Miller, F. J. Martinez, D. C. Angus, W. MacNee, and E. Abraham Interstitial Lung Disease, Lung Cancer, Lung Transplantation, Pulmonary Vascular Disorders, and Sleep-disordered Breathing in AJRCCM in 2004 Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 675 - 685. [Full Text] [PDF]

				D. H. Bryant Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated? Eur. Respir. J., March 1, 2005; 25(3): 402 - 405. [Full Text] [PDF]

				J. J. Egan Obliterative Bronchiolitis after Lung Transplantation: A Repetitive Multiple Injury Airway Disease Am. J. Respir. Crit. Care Med., November 1, 2004; 170(9): 931 - 932. [Full Text] [PDF]